Clinical Trials Browser

Phase 1/2 × INDUSTRY × Tirapazamine × Clear all

NCT02174549 2026-04-20

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Phase 1/2 Recruiting

EndocrineGastrointestinalNET

Hypoxia, Carcinoma, Hepatocellular, Neuroendocrine Tumors

NCT06848556 2025-02-27

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular